The FDA’s new Adverse Event Monitoring System for drugs and vaccines merges the agency’s previously separate adverse event reporting systems for drugs, vaccines and other products. Some critics told The Defender the new database does little to solve long-standing problems with the federal government’s follow-up and verification of adverse event reports.
